Internal Medicine, Endocrinology, Diabetes, & Metabolism · Venice, FL
NPI
1316071830
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
1700 E Venice Ave Ste C
Venice, FL, 34292
Phone (941) 499-0800
Groups this clinician bills Medicare through
Medicare paid, 2024
$193K
4,455 services
Medicare patients, 2024
965
Average age 75
Drug cost, 2024
$2.6M
5,015 prescriptions
Company payments, 2025
$1,018
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pooja S Pothiwala was code 99214 (office e&m - established), 1,254 times for 761 patients. In total Pooja S Pothiwala billed 4,455 services in 43 codes, and Medicare paid $193K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,254 | 761 | $88.11 | $110K |
| 95251 Test - Miscellaneous | Office | 434 | 194 | $25.65 | $11K |
| 36415 Venipuncture Blood Collection | Office | 398 | 304 | $8.56 | $3,408 |
| 84439 Clinical Chemistry | Office | 359 | 278 | $8.77 | $3,147 |
| 84443 Clinical Chemistry | Office | 358 | 279 | $16.32 | $5,843 |
| 83036 Blood Count | Office | 322 | 223 | $9.31 | $2,999 |
| 99232 Hospital E&M - Subsequent | Facility | 148 | 51 | $60.74 | $8,990 |
| 99204 Office E&M - New | Office | 129 | 129 | $116.57 | $15K |
| 80053 Clinical Chemistry | Office | 129 | 110 | $10.19 | $1,314 |
| 80048 Clinical Chemistry | Office | 114 | 102 | $8.14 | $928 |
| 99213 Office E&M - Established | Office | 91 | 84 | $61.66 | $5,611 |
| 82570 Clinical Chemistry | Office | 90 | 86 | $5.02 | $452 |
| 82043 Clinical Chemistry | Office | 90 | 86 | $5.60 | $504 |
| 80061 Clinical Chemistry | Office | 72 | 63 | $13.12 | $945 |
| 84481 Clinical Chemistry | Office | 70 | 53 | $16.60 | $1,162 |
By year: 2022 $120K for 2,675 services; 2023 $174K for 3,877 services; 2024 $193K for 4,455 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 398 | 304 | $8.56 | $3,408 |
| 84439 Clinical Chemistry | 359 | 278 | $8.77 | $3,147 |
| 84443 Clinical Chemistry | 358 | 279 | $16.32 | $5,843 |
| 83036 Blood Count | 322 | 223 | $9.31 | $2,999 |
| 80053 Clinical Chemistry | 129 | 110 | $10.19 | $1,314 |
| 80048 Clinical Chemistry | 114 | 102 | $8.14 | $928 |
| 82043 Clinical Chemistry | 90 | 86 | $5.60 | $504 |
| 82570 Clinical Chemistry | 90 | 86 | $5.02 | $452 |
| 80061 Clinical Chemistry | 72 | 63 | $13.12 | $945 |
| 84481 Clinical Chemistry | 70 | 53 | $16.60 | $1,162 |
Medicare prescription drug claims, 2024
In 2024, the drug Pooja S Pothiwala prescribed most often to Medicare patients was Levothyroxine Sodium, with 784 prescriptions and refills. In total Pooja S Pothiwala wrote 5,015 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 784 | 2,254 | 246 | $6,690 |
| Metformin Hcl Generic | 251 | 683 | 82 | $1,528 |
| Synthroid Levothyroxine Sodium | 214 | 583 | 65 | $18K |
| Ozempic Semaglutide | 210 | 397 | 63 | $354K |
| Mounjaro Tirzepatide | 192 | 271 | 48 | $284K |
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 187 | 394 | 52 | $266K |
| Metformin Hcl Er Metformin Hcl | 186 | 545 | 78 | $2,770 |
| Jardiance Empagliflozin | 180 | 426 | 58 | $243K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 173 | 478 | 69 | $27K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 163 | 425 | 70 | $18K |
| Methimazole Generic | 154 | 418 | 50 | $1,019 |
| Tresiba Flextouch U-100 Insulin Degludec | 125 | 355 | 51 | $116K |
| Trulicity Dulaglutide | 107 | 182 | 30 | $178K |
| Tresiba Flextouch U-200 Insulin Degludec | 102 | 246 | 36 | $143K |
| Novolog Flexpen Insulin Aspart | 93 | 215 | 40 | $26K |
Brand drugs: 2,969 claims; generic drugs: 1,574 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pooja S Pothiwala $1,018 ($1,018 in general payments such as food, travel and fees) from 17 companies. The largest payer was Abbott Laboratories with $148.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 7 | $148 |
| Tandem Diabetes Care, Inc. TNDM | 5 | $122 |
| Novo Nordisk Inc NVO | 5 | $119 |
| Xeris Pharmaceuticals, Inc. | 4 | $87.69 |
| Corcept Therapeutics CORT | 4 | $84.36 |
| Lilly USA, LLC LLY | 3 | $69.54 |
| Dexcom, Inc. DXCM | 3 | $60.23 |
| Medtronic, Inc. MDT | 2 | $53.53 |
| Beta Bionics, Inc. BBNX | 2 | $51.63 |
| Abbvie Inc. ABBV | 2 | $48.01 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.